Challenges in measuring medication adherence: experiences from a controlled trial
Tóm tắt
Measurement of adherence is complex and many methods, both direct and indirect are used; there is no universal gold standard. In this article, we share our experiences in a randomised controlled study, the Hypertension Adherence Program in Pharmacy trial, evaluating a community pharmacy-based intervention for improving adherence to antihypertensive medication. Several objective and subjective measures of adherence (Morisky score, TABS score, MedsIndex, Medicines Possession Ratio) were used, but produced varying results, limiting confidence in the conclusions that could be drawn. Despite using a specifically designed data mining software program to identify potentially nonadherent patients from dispensing records, many participants were found to be adherent by the self reported Morisky scale. A lesson to be learned when targeting people for interventions to improve adherence is that information from dispensing records should be supplemented by other methods in order to identify patients most in need of assistance.
Tài liệu tham khảo
Sabaté E. World Health Organization. Adherence to long-term therapies: evidence for action. 2003. Geneva: World Health Organisation, 2003. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed August 2013.
Farmer K. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90.
Lau R, Stewart K, Mc Namara K, Jackson SL, Hughes JD, Peterson GM, et al. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomized controlled trial. BMC Health Serv Res. 2010;10(1):34.
Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). MJA. 2006;185(9):487–9.
Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239–45.
Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2008;6:48. doi:10.1186/1471-2261-6-48.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147–52.
Vrijens B, Vincze G, Kristant P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–7.
Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004–2006. MJA. 2008;188(4):224–7.
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.
Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, Mcneil JJ, Atkins RC. Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA. 2003;179(3):135–9.
Janus ED, Bubker SJ, Kilkkinen A, Mc Namara KM, Philpot B, Tideman P, et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006. Intern Med J. 2008;38:879–86.
Brown MJ, Cruickshank JK, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens. 2003;17(2):81–6.
Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the beliefs and behaviour questionnaire (BBQ). Patient Educ Couns. 2006;64:50–60.
Pharmacy Guild of Australia. MedsIndex: a medicines compliance indicator. Canberra: The Pharmacy Guild of Australia, 2008. http://www.guild.org.au/iwov-resources/documents_members/The_Guild/tab-Business_Support/eHealth_and_IT_Tools/MedsIndex/PGA1596_02A_MedsIndex_Brochure_Final.pdf. Accessed June 2013.
Steiner JF, Prochazka AV. The assessment of refill adherence using pharmacy records, methods, validity and application. J Clin Epidemiol. 1997;50(1):105–16.